We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Oscillate Plc | AQSE:MUSH | Aquis Stock Exchange | Ordinary Share | GB00BJN5JS53 |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 0.625 | 0.50 | 0.75 | 0.625 | 0.625 | 0.625 | 0.00 | 06:59:01 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From May 2024 to Jun 2024
PR Newswire
LONDON, United Kingdom, June 07
7 June 2024
Oscillate Plc
("Oscillate" or the "Company")
Investee Company Update: Shortwave
Oscillate (AQSE: MUSH) is pleased to note the announcement today by Shortwave Life Sciences Plc (formerly Psych Capital Plc).
The full announcement can be found at: https://www.aquis.eu/stock-exchange/announcements/4644458
Steve Xerri, Executive Director of Oscillated stated: "It's reassuring that Shortwave is on track, rebranding and embedding the Shortwave Pharma business, that was acquired by now renamed Shortwave Life Sciences Plc. For Oscillate, this means that we should continue to measure this investment as material as it has the potential to provide compelling upside in itself.
As a major stakeholder in Shortwave Life Sciences Plc, we continue to hold 46,042,516 ordinary shares, representing approximately 12.73% of the issued share capital."
The Directors of the Company accept responsibility for the contents of this announcement.
Enquiries
Company
John Treacy
ir@oscillateplc.com
https://oscillateplc.com
Peterhouse Capital Limited
Aquis Growth Market Corporate Adviser
Telephone: +44 (0) 20 7469 0930
1 Year Oscillate Chart |
1 Month Oscillate Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
